SenaHill Partners, LP
Neil DeSena is a distinguished finance professional and one of the founding Managing Partners of SenaHill Partners, LP, a pioneering merchant bank dedicated to the financial technology sector. In addition to this role, Neil serves as a Board Member at Symbiont.io, contributing to the integration of blockchain technology within traditional finance. As an Advisory Board Member for Excision BioTherapeutics Inc., Neil supports the advancement of gene editing therapeutics. Neil also presides over DeSena Investments, a family office specializing in Angel round investing, and has held positions as an Independent Board Member at Pico Quantitative Trading and Managing Director at Goldman Sachs, where leadership of the REDI Product Development initiative was undertaken. Earlier, Neil was a Partner and Managing Director at Spear, Leeds & Kellogg, leading the REDI Products Division.
This person is not in any teams
SenaHill Partners, LP
SenaHill Partners is a merchant bank offering a full suite of investment, operating and advisory services to the Financial Technology sector. We combine proven domain and operational expertise with an unparalleled industry advisor network to deliver superior services that drive measurable results for our partner companies. Our powerful business model includes two primary and complementary offerings: Principal Investing with the SenaHill Investment Group, LLC and Investment Banking with SenaHill Advisors, LLC. From inception and capital raising through scaling and growth to strategic exit, SenaHill bridges the gap between disruptive FinTech innovators and global financial institutions to bring a new level of efficiency, collaboration and success to the industry.